A new strategy — an injectable antibody — for lowering blood lipids and thereby potentially preventing coronary
artery disease and other conditions caused by the build - up of fats, cholesterol, and other substances
on the
artery walls, is supported by
findings from two new studies from researchers in the Perelman School of Medicine at the University of Pennsylvania.